Fundraising Fox

SARAS CAPITAL

Venture capitalActively deploying

Canterbury

Fox Verdict
Sign up to see your fit

Fund manager profile

SARAS CAPITAL is a venture fund manager based in Canterbury. SEC filings show 2 venture funds on record, most recently SARAS CAPITAL II LP filed December 2025.

Source: SEC EDGAR Form D filings. Firm website data not yet available.

HQ
Canterbury
Founded
2024
Last 12 months
4 investments
Tracked investments
8

What they invest in

from 8 of 8 portfolio companies

AI & Machine Learning ×4Enterprise Software ×4Biotech ×3SaaS ×3Data & Infrastructure ×2Deep Tech ×2Developer Tools ×2Healthtech ×2

HQs:United States×4Germany×1France×1United Kingdom×1

Investments · 8 tracked

founders shown can be your intro path

By year:2026 · 32025 · 14 dated

Kyronkyron.bio✓ verified

kyron.bio develops protein and antibody therapeutics using a glycan-engineering platform that controls glycosylation patterns.

BiotechDeep TechHealthtechParis, FR

Emilia McLaughlin(Cofounder)inDr. Emilia McLaughlin(CEO & Founder)

Co-investorsEntrepreneur FirstHCVCVerve VenturesGSV Ventures

Biographicagraphica.bioinJan 2026

Biographica (Graphica) uses multi-modal machine learning and high-throughput sequencing to identify and prioritize genetic targets for crop gene-editing, working with trait developers to design effective edits.

AgTechAI & Machine LearningBiotechLondon, GB

Cecy Price(CEO)inDominic Hall(CTO)in

Co-investorsEntrepreneur FirstFaberFaber Capital SCR SASie VenturesSuperSeedCardumen Capital+4 more

Cellbytecellbyte.cominNov 2025 · $2.8M

Cellbyte automates regulatory workflows and data analysis for pharmaceutical drug launches, helping manufacturers prepare treatments for global markets faster.

AI & Machine LearningEnterprise SoftwareHealthtechMedical DevicesSaaSMunich, DE

Felix Steinbrenner(Co-Founder & CEO)inDanielSamuel

Co-investorsFrontline VenturesPace VenturesY CombinatorSpringboard Health Angels

Convergerunconverge.comin𝕏Jan 2026 · $25M

Converge is an AI-native growth platform for direct-to-consumer brands that automates media buying, attribution analysis, and reporting through agentic AI.

AdTechAI & Machine LearningDirect to ConsumerE-commerceEnterprise SoftwareSaaSNew York City, US

Jan-Henrik Lambrechts(Founder)inJerome Billiet(Founder)inThomas Holvoet(Founder)in

Co-investorsEntourage VenturesY CombinatorBessemer Venture PartnersTLV PartnersVintage Investment Partners

Converge Bioconverge-bio.cominJan 2026 · $25M

Converge Bio develops generative AI models trained on DNA, RNA, and protein sequences to support drug discovery and development for biotech and pharmaceutical companies.

AI & Machine LearningBiotechDeep TechClaymont, US

Dov Gertz(Executive Officer, Director)inOded Kalev(Executive Officer, Director)inIddo Weiner(Executive Officer)in

BoardShahar Tzafrir(Director)inAndrew Hedin(Director)in

Co-investorsBessemer Venture PartnersTLV PartnersVintage Investment Partners

Parseparse.comAcquired

Parse provides cloud-based backend infrastructure and tools for developers to build applications across mobile, desktop, and embedded platforms, including data storage, push notifications, and usage analytics.

Developer ToolsEnterprise SoftwareSan Francisco, US

Kevin Lacker(Founder/CTO)in

Co-investorsY Combinator

Parseparse.botin

Parse provides an API platform that converts web actions and data retrieval from any website into single API calls without running a browser.

Data & InfrastructureDeveloper ToolsEnterprise SoftwareSaaSSan Francisco, US

Alex Forman(Founder)in

Co-investorsY Combinator

Parseparse.lyin𝕏

Parse.ly is a content analytics and audience intelligence platform offering a real-time dashboard, a content recommendation API, a data pipeline to warehouses, and AI-driven insights.

Data & InfrastructureMarketing TechMedia & Entertainment

Co-investorsHaatchHorizon Technology FinanceJanus Henderson InvestorsSahsen VenturesSoleus Capital

Portfolio news

latest coverage across their companies

Frequently asked questions

Where is SARAS CAPITAL located?
SARAS CAPITAL is headquartered in Canterbury.